Consolidated Statement of Operations - USD ($)	3 Months Ended		6 Months Ended
	Apr. 30, 2019	Apr. 30, 2018	Apr. 30, 2019	Apr. 30, 2018
Details
Revenues	$ 3,634,124	$ 3,501,842	$ 7,290,248	$ 7,015,329
Cost of expenses:
Cost of revenues	2,036,347	2,026,121	4,068,766	4,265,421
Research and development expenses	139,318	149,163	283,273	303,829
Selling, general, and administrative expenses	2,422,361	2,276,284	4,668,259	4,497,113
Operating Expenses	4,598,026	4,451,568	9,020,298	9,066,363
Loss from operations	(963,902)	(949,726)	(1,730,050)	(2,051,034)
Interest expense - related party	167,765	70,088	335,684	135,800
Other loss	0	4,506	0	4,506
Loss before income taxes	(1,131,667)	(1,024,320)	(2,065,734)	(2,191,340)
Provision for income taxes	0	0	0	0
Net loss	$ (1,131,667)	$ (1,024,320)	$ (2,065,734)	$ (2,191,340)
Net loss per common share - basic	$ (0.15)	$ (0.13)	$ (0.27)	$ (0.28)
Net loss per common share - diluted	$ (0.15)	$ (0.13)	$ (0.27)	$ (0.28)
Weighted average number of common shares outstanding - basic	7,696,091	7,696,091	7,696,091	7,696,091
Weighted average number of common shares outstanding - diluted	7,696,091	7,696,091	7,696,091	7,696,091